Intimation of Schedule of Analyst/Institutional Investor Meeting

Board & Shareholder Meetings View source PDF

SUNPHARMA · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reaction · full curve 14 horizons · vs prior close

+0.1%1-day move

₹1840.00

prior close

₹1840.00

base price

In-mkt

timing

5m10m15m30m1D2D3D4D5D7D15D1M2M3M

+0.1+0.1+0.0+0.1+0.1+0.0-2.0-2.7-2.9-3.2-1.9+1.2+7.2—

Up moveDown movePending

AI summary

Sun Pharma has disclosed the schedule of an upcoming analyst/institutional investor meeting under SEBI's disclosure norms. The meeting is scheduled for 27 May 2026 as part of the 360 ONE Capital (B&K) 16th Annual Investor Conference (TRINITY INDIA 2026) in Mumbai. The format will include both group and one-on-one sessions. The company has explicitly stated it will not disclose any Unpublished Price Sensitive Information (UPSI) during these meetings. The schedule is subject to change due to exigencies on either side.

Likely market impact

This is a routine regulatory disclosure with no direct impact on the stock. It reflects Sun Pharma's ongoing engagement with institutional investors. No price-sensitive information is being shared.